Skip to main content
Caplight Logo









RX

RX

Private
DaejeonEnergy & Sustainabilityhttps://rx.energy/

Last Round

Grant

Jul 1, 2026

Total Funding Raised

$2.39M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

RX is a nuclear engineering company that specializes in Small Modular Reactor (SMR) design, licensing, and AI-powered plant solutions.

Sector

Energy & Sustainability

Verticals

Energy Management, Smart Grid, Renewable Energy, EV Charging

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

distributed energy resource management systemDERMSgrid edge controlenergy orchestrationsmart gridvirtual power plantVPPdistributed energy resourcesDERsgrid modernizationrenewable energy integrationgrid stabilityEV charging managementSaaS energy platformutility software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RX Comparables

Compare RX with similar companies based on industry and business-model similarity.

RX comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Camus Energy
78%
Oracle Corporation
75%
Mitsubishi Electric Corporation
73%

RX Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 1, 2026
AcceleratorApr 1, 2026
Pre SeedJan 1, 2026
GrantOct 1, 2024
SeedAug 1, 2024
Grant
Apr 1, 2024

RX Investors

Notable investors and investment history

RX investors
InvestorRounds
CKD Venture CapitalSeed, Pre Seed
A VenturesSeed, Pre Seed
Bluepoint PartnersSeed, Pre Seed
Company K PartnersSeed, Pre Seed
Banks Foundation for Young EntrepreneursAccelerator
KT InvestmentSeed, Pre Seed
Mirae Asset Venture InvestmentSeed, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 18, 2026

    Grew 500% QoQ from 1 to 6 employees.

  • Jul 1, 2026

    $14.5M grant from the Government of South Korea

RX Filings

Explore SEC and related filing metadata, where available.

RX filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about RX's valuation, stock price, and market status.

Is RX a public or private company?

RX is a private company.

What is the current stock price of RX?

RX is a private company with no public stock price. Caplight tracks RX's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is RX worth (valuation)?

Valuation information for RX is not publicly available.

Can I buy RX stock?

RX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was RX's last funding round?

Funding round information for RX is not publicly available.

Who are the main investors in RX?

Investor information for RX is not publicly disclosed.

Will RX IPO soon?

No public IPO plans have been announced for RX.

How can I track RX secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RX's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDaejeon
Employee Range6
Year Founded2023
Last FundingJul 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?